The Enterprise Value as of November 2024 (TTM) for NeuroPace, Inc. (NPCE) is 347.61M

According to NeuroPace, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 347.61M. This represents a change of 5.90% compared to the average of 328.25M of the last 4 quarters.

NeuroPace, Inc. (NPCE) Historical Enterprise Value (quarterly & annually)

How has NPCE Enterprise Value performed in the past?

The mean historical Enterprise Value of NeuroPace, Inc. over the last ten years is 394.50M. The current 347.61M Enterprise Value has changed 8.71% with respect to the historical average. Over the past ten years (40 quarters), NPCE's Enterprise Value was at its highest in in the March 2021 quarter at 594.45M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

NeuroPace, Inc. (NPCE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeuroPace, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroPace, Inc. (NPCE) Average Enterprise Value

How has NPCE Enterprise Value performed in the past?

The current Enterprise Value of NeuroPace, Inc. (NPCE) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NeuroPace, Inc. (NPCE) Enterprise Value vs. Peers

How is NPCE’s Enterprise Value compared to its peers?

NeuroPace, Inc.’s Enterprise Value is greater than Electromed, Inc. (238.10M), less than OrthoPediatrics Corp. (611.40M), less than Surmodics, Inc. (554.56M), less than Paragon 28, Inc. (910.24M), greater than Nevro Corp. (343.98M), less than NuVasive, Inc. (2.84B), less than Integer Holdings Corporation (5.77B), less than Glaukos Corporation (8.00B), less than CONMED Corporation (3.22B), greater than ProSomnus, Inc. Common Stock (40.81M), greater than Anika Therapeutics, Inc. (213.70M), less than Heska Corporation (1.26B), greater than Pulmonx Corporation (260.62M), less than IRadimed Corporation (623.15M), less than Orthofix Medical Inc. (829.81M), greater than CVRx, Inc. (310.32M), less than Artivion, Inc. (1.49B),

Build a custom stock screener for NeuroPace, Inc. (NPCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroPace, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroPace, Inc. (NPCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroPace, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.